Topiramate: Screen patients for pregnancy risk, says drug agency

Topiramate, a migraine and antiseizure medicine, will no longer be prescribed to women or girls unless they fulfil the requirements of the Pregnancy Prevention Programme, the Medicines and Healthcare Products Regulatory Agency (MHRA) has announced.1

While topiramate has been contraindicated in pregnancy for the prevention of migraine since 2010, the drug is now also contraindicated …